PHARMA EVIDENCE ApS: Financial statements 2020
CVR: 34586519
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,072,666 and a net result of DKK 643,333 compared with DKK 220,887 the year before. That is an increase of 43.2% compared with the year before. Equity in the 2020 report amounted to DKK 1,293,234. The solvency ratio was 69.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,072,666
- Profit/Loss
- DKK 643,333
- Equity
- DKK 1,293,234
- Total Assets
- DKK 1,850,387
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.1 mio. | 643 t. | 1.3 mio. | 1 |
| 2019 | - | 749 t. | 221 t. | 650 t. | - |
| 2018 | - | 1.1 mio. | 123 t. | 429 t. | - |
| 2017 | - | 625 t. | 280 t. | 306 t. | 1 |
| 2016 | - | -28 t. | -48 t. | 26 t. | - |
Official annual report
How creditworthy is PHARMA EVIDENCE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
PHARMA EVIDENCE ApS has published its annual report for 2019. Gross profit came to DKK 749,320, and the net result was DKK 220,887.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.